Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both?

Detalles Bibliográficos
Autores principales: Stewart, Paul M., Tomlinson, Jeremy W.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606863/
https://www.ncbi.nlm.nih.gov/pubmed/19114723
http://dx.doi.org/10.2337/db08-1404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606863/
https://www.ncbi.nlm.nih.gov/pubmed/19114723
http://dx.doi.org/10.2337/db08-1404

Ejemplares similares